Profil
William Fricker formerly worked at Immunomedics, Inc., as Controller from 2018 to 2020, Eleison Pharmaceuticals, Inc., as Chief Financial Officer from 2022 to 2023, NRX Pharmaceuticals, Inc., as Chief Financial Officer & Treasurer in 2021, J.
M.
Huber Micropowders, Inc., as VP, Global Controller & Chief Accounting Officer, NeuroTrauma Sciences LLC, as Chief Financial Officer from 2023 to 2024, and Annovis Bio, Inc., as Chief Financial Officer from 2024 to 2025.
Mr. Fricker received his undergraduate degree from The Pennsylvania State University.
Ehemalige bekannte Positionen von William Fricker
| Unternehmen | Position | Ende |
|---|---|---|
| ANNOVIS BIO, INC. | Finanzdirektor/CFO | 27.03.2025 |
NeuroTrauma Sciences LLC
NeuroTrauma Sciences LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat brain injury | Finanzdirektor/CFO | 01.04.2024 |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes clinical stage drug candidates for orphan cancers | Finanzdirektor/CFO | 01.01.2023 |
| NRX PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 30.08.2021 |
| IMMUNOMEDICS, INC. | Comptroller/Controller/Auditor | 01.10.2020 |
Ausbildung von William Fricker
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Annovis Bio, Inc.
Annovis Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes clinical stage drug candidates for orphan cancers | Health Technology |
NeuroTrauma Sciences LLC
NeuroTrauma Sciences LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat brain injury | Health Technology |
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company | Health Technology |
J. M. Huber Micropowders, Inc.
J. M. Huber Micropowders, Inc. Chemicals: SpecialtyProcess Industries Manufactures chemicals and minerals | Process Industries |
















